↓ Skip to main content

Nicergoline for dementia and other age associated forms of cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, October 2001
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
4 X users
wikipedia
8 Wikipedia pages

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
170 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nicergoline for dementia and other age associated forms of cognitive impairment
Published in
Cochrane database of systematic reviews, October 2001
DOI 10.1002/14651858.cd003159
Pubmed ID
Authors

Mario Fioravanti, Leon Flicker

Abstract

Nicergoline is an ergot derivative currently in use in over fifty countries for more than three decades, for the treatment of cognitive, affective, and behavioral disorders of older people. It was initially considered as a vasoactive drug and mainly prescribed for cerebrovascular disorders. Recent findings suggest other actions which has provided a rationale for the use of nicergoline for the treatment of various forms of dementia, including Alzheimer's Disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Germany 1 <1%
Unknown 168 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 24 14%
Student > Master 20 12%
Researcher 18 11%
Student > Bachelor 17 10%
Other 9 5%
Other 30 18%
Unknown 52 31%
Readers by discipline Count As %
Medicine and Dentistry 43 25%
Psychology 19 11%
Agricultural and Biological Sciences 9 5%
Neuroscience 7 4%
Social Sciences 7 4%
Other 27 16%
Unknown 58 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2022.
All research outputs
#6,523,781
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,793
of 11,499 outputs
Outputs of similar age
#13,436
of 45,762 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 24 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 45,762 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.